ask="2.46"
ask_size="200"
average_daily_volume="548340"
bid="2.30"
bid_size="15000"
book_value="4.01"
change="-0.02"
change_from_200_day_moving_average="-2.62"
change_from_50_day_moving_average="0.15"
change_from_52_week_high="-6.96"
change_From_52_week_low="0.39"
change_in_percent="-0.83%"
close="2.39"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.09"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.42"
high_52_weeks="9.35"
last_trade_date="2/9/2017"
last_trade_price="2.39"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.35"
low_52_weeks="2.00"
market_capitalization="37.15M"
moving_average_200_day="5.01"
moving_average_50_day="2.24"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="2.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-52.25%"
percent_change_from_50_day_moving_average="+6.65%"
percent_change_from_52_week_high="-74.44%"
percent_change_from_52_week_low="+19.50%"
previous_close="2.41"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.60"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.44"
stock_exchange="NGM"
symbol="NVLS"
volume="102177"
weeks_range_52="2.00 - 9.35"
